Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Global guidelines and initiatives from the European Confederation of Medical Mycology to improve patient care and research worldwide: New leadership is about working together.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • Corporate Authors:
      European Confederation of Medical Mycology (ECMM)
    • المصدر:
      Publisher: Grosse Verlag Country of Publication: Germany NLM ID: 8805008 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-0507 (Electronic) Linking ISSN: 09337407 NLM ISO Abbreviation: Mycoses Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: Berlin : Grosse Verlag, [1988?-
    • الموضوع:
      Mycoses/*drug therapy; Biomedical Research ; Europe ; Fungi/drug effects ; Fungi/genetics ; Fungi/isolation & purification ; Fungi/physiology ; Humans ; Leadership ; Mycology ; Mycoses/diagnosis ; Mycoses/microbiology ; Patient Care/standards ; Practice Guidelines as Topic
    • نبذة مختصرة :
      Invasive mycoses present a global challenge with expansion into new hosts, emergence of new pathogens, and development of multidrug resistance. In parallel, new antifungal agents and advanced laboratory diagnostic systems are being developed. In response to these evolving challenges, the European Confederation of Medical Mycology (ECMM) is committed to providing international expertise, guidance, and leadership with the key objectives of improving diagnosis, treatment, outcome, and survival of persons with invasive fungal diseases. Representing 25 affiliated National Medical Mycology Societies, the ECMM has developed several major ways to achieving these critical objectives: (a) tasking specific medical mycology working groups; (b) founding the ECMM Academy and Fellow program (FECMM); (c) expanding the goals of ECMM beyond the European region; (d) implementing the ECMM Excellence Centre Initiative in Europe; and (e) the ECMM Global Guidelines and Neglected Orphan Disease Guidance Initiatives focusing on mucormycosis, rare mould diseases, rare yeast diseases, and endemic mycoses. We believe that these important initiatives and other strategies of the ECMM will advance the field of medical mycology and improve the outcome of patients with invasive mycoses worldwide.
      (© 2018 The Authors. Mycoses Published by Blackwell Verlag GmbH.)
    • Grant Information:
      Gilead; Merck; Basilea; Pfizer; MSD; Astella; Pathoquest; Gilead Sciences Inc.; United Medical; TEVA; IMMY; Actelion; Amplyx; Arsanis; AstraZeneca; Bayer; Cidara; F2G; GSK; Leeds University; Matinas; Medicines Company; MedPace; Melinta; Miltenyi; Rempex; Roche; Sanofi Pasteur; Scynexis; Seres
    • Contributed Indexing:
      Keywords: Aspergillus; Candida; aspergillosis; epidemiology; guideline; low resource; mucormycoses; recommendation
    • الموضوع:
      Date Created: 20180808 Date Completed: 20181218 Latest Revision: 20220410
    • الموضوع:
      20240829
    • الرقم المعرف:
      10.1111/myc.12836
    • الرقم المعرف:
      30086186